A business in context

XBIO research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-10-22 · 8029 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 8-K · Current report

    Report date 2026-09-23 · 0001683168-26-007340 · Items 7.01,9.01

  2. 8-K · Current report

    Report date 2026-09-14 · 0001683168-26-007181 · Items 1.01,3.02,7.01,9.01

  3. 8-K · Current report

    Report date 2026-08-07 · 0001683168-26-006077 · Items 2.02,9.01

  4. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001683168-26-006061

  5. 8-K · Current report

    Report date 2026-05-13 · 0001683168-26-003766 · Items 2.02,9.01

  6. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001683168-26-003727

  7. 10-K/A · Annual report

    Report date 2025-12-31 · 0001683168-26-003207

  8. 8-K · Current report

    Report date 2026-04-21 · 0001683168-26-003203 · Items 5.02,9.01

  9. 4 · Ownership change

    Report date 2026-04-21 · 0001683168-26-003163

  10. 8-K · Current report

    Report date 2026-03-13 · 0001683168-26-001744 · Items 2.02,9.01

  11. 10-K · Annual report

    Report date 2025-12-31 · 0001683168-26-001737

  12. 8-K · Current report

    Report date 2026-01-08 · 0001683168-26-000196 · Items 8.01

  13. 4 · Ownership change

    Report date 2025-12-31 · 0001683168-26-000104

  14. 4 · Ownership change

    Report date 2025-12-31 · 0001683168-26-000103

  15. 4 · Ownership change

    Report date 2025-12-31 · 0001683168-26-000102

  16. 4 · Ownership change

    Report date 2025-12-31 · 0001683168-26-000101

  17. 8-K · Current report

    Report date 2025-12-11 · 0001683168-25-009076 · Items 7.01,9.01

  18. 8-K · Current report

    Report date 2025-11-13 · 0001683168-25-008288 · Items 2.02,9.01

  19. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001683168-25-008259

  20. DEF 14A · Proxy statement

    Report date 2025-12-11 · 0001683168-25-007872

  21. 8-K · Current report

    Report date 2025-10-10 · 0001683168-25-007528 · Items 1.01,8.01,9.01

  22. 8-K · Current report

    Report date 2025-08-13 · 0001683168-25-006001 · Items 2.02,9.01

  23. 10-Q · Quarterly report

    Report date 2025-06-30 · 0001683168-25-005983

  24. 8-K · Current report

    Report date 2025-05-14 · 0001683168-25-003513 · Items 2.02,9.01

  25. 10-Q · Quarterly report

    Report date 2025-03-31 · 0001683168-25-003496

  26. 10-K/A · Annual report

    Report date 2024-12-31 · 0001683168-25-003493

  27. 10-K/A · Annual report

    Report date 2024-12-31 · 0001683168-25-002939

  28. 8-K · Current report

    Report date 2025-04-08 · 0001683168-25-002396 · Items 4.01,9.01

  29. 8-K/A · Current report

    Report date 2025-03-19 · 0001683168-25-001712 · Items 9.01

  30. 8-K · Current report

    Report date 2025-03-19 · 0001683168-25-001693 · Items 2.02,9.01

  31. 10-K · Annual report

    Report date 2024-12-31 · 0001683168-25-001686

  32. 4 · Ownership change

    Report date 2024-12-11 · 0001683168-24-008720

  33. 4 · Ownership change

    Report date 2024-12-11 · 0001683168-24-008719

  34. 4 · Ownership change

    Report date 2024-12-11 · 0001683168-24-008718

  35. 8-K · Current report

    Report date 2024-12-11 · 0001683168-24-008712 · Items 5.07

  36. 8-K · Current report

    Report date 2024-11-13 · 0001683168-24-007929 · Items 2.02,9.01

  37. 10-Q · Quarterly report

    Report date 2024-09-30 · 0001683168-24-007903

  38. 8-K · Current report

    Report date 2024-11-01 · 0001683168-24-007710 · Items 1.01,7.01,9.01

  39. 8-K · Current report

    Report date 2024-10-29 · 0001683168-24-007527 · Items 5.02

  40. DEF 14A · Proxy statement

    Report date 2024-12-11 · 0001683168-24-007517

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-10-15 · 2026 Q3: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 0 transaction rows0SGrant / award: 0 transaction rows0AExercise / conversion: 0 transaction rows0MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

0 matching transaction rows.

No matching transaction rows in the covered quarter. This does not establish that no insider transactions occurred.

Identity & relationships

Wikidata structured data · retrieved 2026-10-15 · 1663 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001534525Xenetic Biosciences, Inc.

No parent relationship is available in this import; this is not proof of independence.

Legal Entity Identifier
5493002WV0KYX8JXAH52
GLEIF legal name
XENETIC BIOSCIENCES, INC.
Entity / LEI registration status
ACTIVE / LAPSED
Reference data updated
2023-08-04T15:42:32Z

direct-parent: no parent LEI supplied

ultimate-parent: no parent LEI supplied

GLEIF legal entity reference data · retrieved 2026-10-15 · 1199 checked identities; 0 unavailable records

Search names and former names

View Wikidata identity and references ↗

  • Xenetic Biosciences (United States) · alias · wikidata
  • General Sales & Leasing, Inc. · former SEC name · 2013-02-27 to 2014-01-10
  • GENERAL AIRCRAFT INC. · former SEC name · 2011-11-21 to 2013-02-12
Explore headquarters map ↗

Revenue in constant purchasing power

USD revenue expressed in 2026-09 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2024-12-31$2.50M$2.69M
2023-12-31$2.54M$2.81M
2022-12-31$1.71M$1.96M
2021-12-31$1.16M$1.44M
2020-12-31$436.9K$568.8K
2019-12-31$17.1K$22.5K
2018-12-31$0$0
2017-12-31$7.58M$10.43M

Bureau of Labor Statistics · retrieved 2026-10-22 · 9 selected series; gaps remain missing

Explore the CPI history ↗